| ID | Sequence | Length | GC content |
|---|---|---|---|
| AGAGAUUUAUUCGAGCUUCGGCGGGGGAGGGAGCGCAGCUGGGCCGCGU… | 11639 nt | 0.4051 | |
| AGAGAUUUAUUCGAGCUUCGGCGGGGGAGGGAGCGCAGCUGGGCCGCGU… | 11704 nt | 0.4050 | |
| GGGUGAUGUCAGCUCUCGACGAAAAUAGAGAGGGAUCGCCUGCAAAUCC… | 12006 nt | 0.4167 |
This gene encodes a member of a family of solute transporter proteins. The membrane-bound protein is the principal transporter that clears the excitatory neurotransmitter glutamate from the extracellular space at synapses in the central nervous system. Glutamate clearance is necessary for proper synaptic activation and to prevent neuronal damage from excessive activation of glutamate receptors. Improper regulation of this gene is thought to be associated with several neurological disorders. Alternatively spliced transcript variants of this gene have been identified. [provided by RefSeq, Jun 2017]
A study in mice demonstrated that the SLC1A2 was identified as a differentially wired gene in the prefrontal cortex of lines selectively bred for high versus low methamphetamine intake, implicating it in the transcriptomic basis of addiction risk [Hitzemann et al. DOI:10.3390/brainsci9070155]. In human bioinformatics research, the SLC1A2 served as a marker for manual annotation of astrocyte clusters in single-nucleus RNA sequencing analysis of Alzheimer's disease datasets [Weiqi Xue et al. DOI:10.3233/JAD-230559].